ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
A major study at ENDO 2026 finds global heart disease now peaks at ages 50-54, driven by rising obesity and fastest growth in South Asia.
A major study at ENDO 2026 finds global heart disease now peaks at ages 50-54, driven by rising obesity and fastest growth in South Asia.
A major study at ENDO 2026 finds global heart disease now peaks at ages 50-54, driven by rising obesity and fastest growth in South Asia.
A major study at ENDO 2026 finds global heart disease now peaks at ages 50-54, driven by rising obesity and fastest growth in South Asia.
A major study at ENDO 2026 finds global heart disease now peaks at ages 50-54, driven by rising obesity and fastest growth in South Asia.
A UK study of 360,000 adults found healthy sleep patterns linked to a 26% lower risk of pneumonia over 13 years.
Read MoreAs AI overviews from Google and ChatGPT increasingly answer patient health questions, concerns mount over inadvertent HIPAA exposure and misattribution that can erode clinic brand authority. Medical marketing teams must now track these risks into 2027.
Read More
HHS Secretary Kennedy defended the $111.1B FY 2027 budget prioritizing chronic disease prevention and Most Favored Nation drug pricing.
Read More
An OIG audit found CMS lacked sufficient oversight of compounded drugs in Medicare Part D from 2017-2019 due to incomplete data and reporting gaps.
Read More
Scientists discovered altered gene activity in excitatory neurons and microglia in depression patients, offering insights for targeted therapies.
Read More
Abbott survey finds 74% of Americans believe chronic diseases are preventable, citing confusion and costs as key barriers to effective health management.
Read More
The Justice Department reclassified cannabis as Schedule III, allowing FDA-approved medical marijuana research and expanded treatment options.
Read More
New Hampshire Senator Sue Prentiss introduced a bill to require Medicaid coverage for GLP-1 weight loss drugs for patients with BMI over 30.
Read More
The FDA approved the Lumipulse G pTau217/ß-Amyloid 1-42 blood test for early Alzheimer’s detection in adults 55+ with cognitive decline.
Read More
The ‘second brain’ category has been captured for a decade by note-taking apps. But once AI becomes the primary reader of the archive, the architecture has to change. The open brain is what comes next
Read More
